nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—CYP1A2—type 2 diabetes mellitus	0.158	0.602	CbGaD
Pantoprazole—CYP3A4—type 2 diabetes mellitus	0.104	0.398	CbGaD
Pantoprazole—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.0388	0.0771	CbGbCtD
Pantoprazole—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.0351	0.0698	CbGbCtD
Pantoprazole—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0324	0.0644	CbGbCtD
Pantoprazole—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0286	0.0569	CbGbCtD
Pantoprazole—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0164	0.0327	CbGbCtD
Pantoprazole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0156	0.031	CbGbCtD
Pantoprazole—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0147	0.0291	CbGbCtD
Pantoprazole—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0143	0.0285	CbGbCtD
Pantoprazole—ABCG2—Glyburide—type 2 diabetes mellitus	0.0143	0.0284	CbGbCtD
Pantoprazole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0139	0.0276	CbGbCtD
Pantoprazole—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0131	0.026	CbGbCtD
Pantoprazole—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0125	0.0248	CbGbCtD
Pantoprazole—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0125	0.0248	CbGbCtD
Pantoprazole—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0122	0.0242	CbGbCtD
Pantoprazole—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0115	0.0229	CbGbCtD
Pantoprazole—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0111	0.0221	CbGbCtD
Pantoprazole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0106	0.0211	CbGbCtD
Pantoprazole—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0104	0.0206	CbGbCtD
Pantoprazole—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0104	0.0206	CbGbCtD
Pantoprazole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0101	0.02	CbGbCtD
Pantoprazole—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00956	0.019	CbGbCtD
Pantoprazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00935	0.0186	CbGbCtD
Pantoprazole—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00923	0.0184	CbGbCtD
Pantoprazole—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00844	0.0168	CbGbCtD
Pantoprazole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00835	0.0166	CbGbCtD
Pantoprazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00833	0.0166	CbGbCtD
Pantoprazole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0079	0.0157	CbGbCtD
Pantoprazole—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00785	0.0156	CbGbCtD
Pantoprazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00762	0.0151	CbGbCtD
Pantoprazole—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00753	0.015	CbGbCtD
Pantoprazole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00691	0.0137	CbGbCtD
Pantoprazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00666	0.0132	CbGbCtD
Pantoprazole—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00638	0.0127	CbGbCtD
Pantoprazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00602	0.012	CbGbCtD
Pantoprazole—CYP2C19—Losartan—type 2 diabetes mellitus	0.00583	0.0116	CbGbCtD
Pantoprazole—CYP1A2—Losartan—type 2 diabetes mellitus	0.00538	0.0107	CbGbCtD
Pantoprazole—CYP2C9—Glyburide—type 2 diabetes mellitus	0.0053	0.0105	CbGbCtD
Pantoprazole—ABCB1—Glyburide—type 2 diabetes mellitus	0.00515	0.0102	CbGbCtD
Pantoprazole—CYP2C9—Losartan—type 2 diabetes mellitus	0.00485	0.00964	CbGbCtD
Pantoprazole—ABCB1—Losartan—type 2 diabetes mellitus	0.00471	0.00936	CbGbCtD
Pantoprazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00456	0.00907	CbGbCtD
Pantoprazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00438	0.0087	CbGbCtD
Pantoprazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00438	0.0087	CbGbCtD
Pantoprazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00414	0.00823	CbGbCtD
Pantoprazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00308	0.00613	CbGbCtD
Pantoprazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00282	0.00561	CbGbCtD
Pantoprazole—Omeprazole—CYP11A1—type 2 diabetes mellitus	0.000847	0.301	CrCbGaD
Pantoprazole—Rabeprazole—CYP1A2—type 2 diabetes mellitus	0.000381	0.135	CrCbGaD
Pantoprazole—Esomeprazole—CYP3A4—type 2 diabetes mellitus	0.000349	0.124	CrCbGaD
Pantoprazole—Omeprazole—CYP1A2—type 2 diabetes mellitus	0.000311	0.11	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A2—type 2 diabetes mellitus	0.000284	0.101	CrCbGaD
Pantoprazole—Rabeprazole—CYP3A4—type 2 diabetes mellitus	0.000252	0.0895	CrCbGaD
Pantoprazole—Omeprazole—CYP3A4—type 2 diabetes mellitus	0.000206	0.073	CrCbGaD
Pantoprazole—Lansoprazole—CYP3A4—type 2 diabetes mellitus	0.000188	0.0668	CrCbGaD
Pantoprazole—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.68e-05	0.000271	CcSEcCtD
Pantoprazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	4.68e-05	0.000271	CcSEcCtD
Pantoprazole—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.68e-05	0.000271	CcSEcCtD
Pantoprazole—Vertigo—Losartan—type 2 diabetes mellitus	4.67e-05	0.00027	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.00027	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.67e-05	0.00027	CcSEcCtD
Pantoprazole—Somnolence—Valsartan—type 2 diabetes mellitus	4.66e-05	0.00027	CcSEcCtD
Pantoprazole—Syncope—Losartan—type 2 diabetes mellitus	4.66e-05	0.00027	CcSEcCtD
Pantoprazole—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.65e-05	0.000269	CcSEcCtD
Pantoprazole—Leukopenia—Losartan—type 2 diabetes mellitus	4.65e-05	0.000269	CcSEcCtD
Pantoprazole—Discomfort—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000269	CcSEcCtD
Pantoprazole—Skin disorder—Metformin—type 2 diabetes mellitus	4.64e-05	0.000269	CcSEcCtD
Pantoprazole—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000268	CcSEcCtD
Pantoprazole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.62e-05	0.000267	CcSEcCtD
Pantoprazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.62e-05	0.000267	CcSEcCtD
Pantoprazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.6e-05	0.000266	CcSEcCtD
Pantoprazole—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000266	CcSEcCtD
Pantoprazole—Palpitations—Losartan—type 2 diabetes mellitus	4.59e-05	0.000266	CcSEcCtD
Pantoprazole—Nausea—Glimepiride—type 2 diabetes mellitus	4.58e-05	0.000265	CcSEcCtD
Pantoprazole—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.57e-05	0.000265	CcSEcCtD
Pantoprazole—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.57e-05	0.000265	CcSEcCtD
Pantoprazole—Nausea—Sitagliptin—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Pantoprazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Pantoprazole—Asthenia—Glyburide—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Pantoprazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.56e-05	0.000264	CcSEcCtD
Pantoprazole—Anorexia—Metformin—type 2 diabetes mellitus	4.55e-05	0.000264	CcSEcCtD
Pantoprazole—Cough—Losartan—type 2 diabetes mellitus	4.54e-05	0.000263	CcSEcCtD
Pantoprazole—Urticaria—Gliclazide—type 2 diabetes mellitus	4.54e-05	0.000263	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.53e-05	0.000262	CcSEcCtD
Pantoprazole—Alopecia—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000262	CcSEcCtD
Pantoprazole—Fatigue—Valsartan—type 2 diabetes mellitus	4.52e-05	0.000262	CcSEcCtD
Pantoprazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.51e-05	0.000261	CcSEcCtD
Pantoprazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.51e-05	0.000261	CcSEcCtD
Pantoprazole—Oedema—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000261	CcSEcCtD
Pantoprazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.51e-05	0.000261	CcSEcCtD
Pantoprazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.51e-05	0.000261	CcSEcCtD
Pantoprazole—Pruritus—Glyburide—type 2 diabetes mellitus	4.5e-05	0.00026	CcSEcCtD
Pantoprazole—Mental disorder—Ramipril—type 2 diabetes mellitus	4.49e-05	0.00026	CcSEcCtD
Pantoprazole—Constipation—Valsartan—type 2 diabetes mellitus	4.49e-05	0.00026	CcSEcCtD
Pantoprazole—Infection—Irbesartan—type 2 diabetes mellitus	4.48e-05	0.000259	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000259	CcSEcCtD
Pantoprazole—Fatigue—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000259	CcSEcCtD
Pantoprazole—Hypotension—Metformin—type 2 diabetes mellitus	4.46e-05	0.000258	CcSEcCtD
Pantoprazole—Malnutrition—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000258	CcSEcCtD
Pantoprazole—Shock—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000257	CcSEcCtD
Pantoprazole—Pain—Orlistat—type 2 diabetes mellitus	4.43e-05	0.000257	CcSEcCtD
Pantoprazole—Arthralgia—Losartan—type 2 diabetes mellitus	4.43e-05	0.000256	CcSEcCtD
Pantoprazole—Myalgia—Losartan—type 2 diabetes mellitus	4.43e-05	0.000256	CcSEcCtD
Pantoprazole—Chest pain—Losartan—type 2 diabetes mellitus	4.43e-05	0.000256	CcSEcCtD
Pantoprazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.42e-05	0.000256	CcSEcCtD
Pantoprazole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000256	CcSEcCtD
Pantoprazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.41e-05	0.000256	CcSEcCtD
Pantoprazole—Anxiety—Losartan—type 2 diabetes mellitus	4.41e-05	0.000255	CcSEcCtD
Pantoprazole—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000255	CcSEcCtD
Pantoprazole—Rash—Bromocriptine—type 2 diabetes mellitus	4.39e-05	0.000254	CcSEcCtD
Pantoprazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.38e-05	0.000254	CcSEcCtD
Pantoprazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000254	CcSEcCtD
Pantoprazole—Tension—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000253	CcSEcCtD
Pantoprazole—Discomfort—Losartan—type 2 diabetes mellitus	4.37e-05	0.000253	CcSEcCtD
Pantoprazole—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000253	CcSEcCtD
Pantoprazole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000252	CcSEcCtD
Pantoprazole—Headache—Bromocriptine—type 2 diabetes mellitus	4.36e-05	0.000252	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.35e-05	0.000252	CcSEcCtD
Pantoprazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.35e-05	0.000252	CcSEcCtD
Pantoprazole—Nervousness—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000251	CcSEcCtD
Pantoprazole—Dry mouth—Losartan—type 2 diabetes mellitus	4.33e-05	0.000251	CcSEcCtD
Pantoprazole—Anorexia—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000249	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.29e-05	0.000248	CcSEcCtD
Pantoprazole—Paraesthesia—Metformin—type 2 diabetes mellitus	4.29e-05	0.000248	CcSEcCtD
Pantoprazole—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000248	CcSEcCtD
Pantoprazole—Confusional state—Losartan—type 2 diabetes mellitus	4.28e-05	0.000248	CcSEcCtD
Pantoprazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.27e-05	0.000247	CcSEcCtD
Pantoprazole—Dyspnoea—Metformin—type 2 diabetes mellitus	4.26e-05	0.000247	CcSEcCtD
Pantoprazole—Somnolence—Metformin—type 2 diabetes mellitus	4.25e-05	0.000246	CcSEcCtD
Pantoprazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.24e-05	0.000246	CcSEcCtD
Pantoprazole—Oedema—Losartan—type 2 diabetes mellitus	4.24e-05	0.000246	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.24e-05	0.000245	CcSEcCtD
Pantoprazole—Infection—Losartan—type 2 diabetes mellitus	4.21e-05	0.000244	CcSEcCtD
Pantoprazole—Hypotension—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000244	CcSEcCtD
Pantoprazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.21e-05	0.000244	CcSEcCtD
Pantoprazole—Dyspepsia—Metformin—type 2 diabetes mellitus	4.2e-05	0.000243	CcSEcCtD
Pantoprazole—Tremor—Ramipril—type 2 diabetes mellitus	4.18e-05	0.000242	CcSEcCtD
Pantoprazole—Shock—Losartan—type 2 diabetes mellitus	4.17e-05	0.000242	CcSEcCtD
Pantoprazole—Urticaria—Valsartan—type 2 diabetes mellitus	4.17e-05	0.000241	CcSEcCtD
Pantoprazole—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.16e-05	0.000241	CcSEcCtD
Pantoprazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.15e-05	0.00024	CcSEcCtD
Pantoprazole—Decreased appetite—Metformin—type 2 diabetes mellitus	4.15e-05	0.00024	CcSEcCtD
Pantoprazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.15e-05	0.00024	CcSEcCtD
Pantoprazole—Tachycardia—Losartan—type 2 diabetes mellitus	4.14e-05	0.00024	CcSEcCtD
Pantoprazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000239	CcSEcCtD
Pantoprazole—Nausea—Bromocriptine—type 2 diabetes mellitus	4.13e-05	0.000239	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.12e-05	0.000239	CcSEcCtD
Pantoprazole—Fatigue—Metformin—type 2 diabetes mellitus	4.12e-05	0.000238	CcSEcCtD
Pantoprazole—Urticaria—Orlistat—type 2 diabetes mellitus	4.12e-05	0.000238	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000238	CcSEcCtD
Pantoprazole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Pantoprazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Pantoprazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Pantoprazole—Asthenia—Gliclazide—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Pantoprazole—Agitation—Ramipril—type 2 diabetes mellitus	4.1e-05	0.000237	CcSEcCtD
Pantoprazole—Constipation—Metformin—type 2 diabetes mellitus	4.08e-05	0.000237	CcSEcCtD
Pantoprazole—Angioedema—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000236	CcSEcCtD
Pantoprazole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000234	CcSEcCtD
Pantoprazole—Anorexia—Losartan—type 2 diabetes mellitus	4.04e-05	0.000234	CcSEcCtD
Pantoprazole—Vomiting—Glyburide—type 2 diabetes mellitus	4.04e-05	0.000234	CcSEcCtD
Pantoprazole—Pruritus—Gliclazide—type 2 diabetes mellitus	4.04e-05	0.000234	CcSEcCtD
Pantoprazole—Malaise—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000233	CcSEcCtD
Pantoprazole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000233	CcSEcCtD
Pantoprazole—Rash—Glyburide—type 2 diabetes mellitus	4.01e-05	0.000232	CcSEcCtD
Pantoprazole—Somnolence—Irbesartan—type 2 diabetes mellitus	4.01e-05	0.000232	CcSEcCtD
Pantoprazole—Dermatitis—Glyburide—type 2 diabetes mellitus	4.01e-05	0.000232	CcSEcCtD
Pantoprazole—Vertigo—Ramipril—type 2 diabetes mellitus	4e-05	0.000232	CcSEcCtD
Pantoprazole—Syncope—Ramipril—type 2 diabetes mellitus	4e-05	0.000231	CcSEcCtD
Pantoprazole—Leukopenia—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000231	CcSEcCtD
Pantoprazole—Headache—Glyburide—type 2 diabetes mellitus	3.98e-05	0.000231	CcSEcCtD
Pantoprazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.97e-05	0.00023	CcSEcCtD
Pantoprazole—Hypotension—Losartan—type 2 diabetes mellitus	3.96e-05	0.00023	CcSEcCtD
Pantoprazole—Palpitations—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000228	CcSEcCtD
Pantoprazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.94e-05	0.000228	CcSEcCtD
Pantoprazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000227	CcSEcCtD
Pantoprazole—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000227	CcSEcCtD
Pantoprazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.91e-05	0.000226	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.91e-05	0.000226	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000225	CcSEcCtD
Pantoprazole—Cough—Ramipril—type 2 diabetes mellitus	3.89e-05	0.000225	CcSEcCtD
Pantoprazole—Fatigue—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000225	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.86e-05	0.000224	CcSEcCtD
Pantoprazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.86e-05	0.000224	CcSEcCtD
Pantoprazole—Convulsion—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000224	CcSEcCtD
Pantoprazole—Pain—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000223	CcSEcCtD
Pantoprazole—Constipation—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000223	CcSEcCtD
Pantoprazole—Insomnia—Losartan—type 2 diabetes mellitus	3.84e-05	0.000222	CcSEcCtD
Pantoprazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.82e-05	0.000221	CcSEcCtD
Pantoprazole—Paraesthesia—Losartan—type 2 diabetes mellitus	3.81e-05	0.000221	CcSEcCtD
Pantoprazole—Urticaria—Metformin—type 2 diabetes mellitus	3.79e-05	0.00022	CcSEcCtD
Pantoprazole—Arthralgia—Ramipril—type 2 diabetes mellitus	3.79e-05	0.00022	CcSEcCtD
Pantoprazole—Chest pain—Ramipril—type 2 diabetes mellitus	3.79e-05	0.00022	CcSEcCtD
Pantoprazole—Myalgia—Ramipril—type 2 diabetes mellitus	3.79e-05	0.00022	CcSEcCtD
Pantoprazole—Dyspnoea—Losartan—type 2 diabetes mellitus	3.78e-05	0.000219	CcSEcCtD
Pantoprazole—Anxiety—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000219	CcSEcCtD
Pantoprazole—Nausea—Glyburide—type 2 diabetes mellitus	3.78e-05	0.000219	CcSEcCtD
Pantoprazole—Abdominal pain—Metformin—type 2 diabetes mellitus	3.78e-05	0.000219	CcSEcCtD
Pantoprazole—Dizziness—Gliclazide—type 2 diabetes mellitus	3.78e-05	0.000219	CcSEcCtD
Pantoprazole—Somnolence—Losartan—type 2 diabetes mellitus	3.77e-05	0.000218	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000218	CcSEcCtD
Pantoprazole—Asthenia—Valsartan—type 2 diabetes mellitus	3.76e-05	0.000218	CcSEcCtD
Pantoprazole—Discomfort—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000217	CcSEcCtD
Pantoprazole—Dyspepsia—Losartan—type 2 diabetes mellitus	3.73e-05	0.000216	CcSEcCtD
Pantoprazole—Asthenia—Orlistat—type 2 diabetes mellitus	3.72e-05	0.000215	CcSEcCtD
Pantoprazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000215	CcSEcCtD
Pantoprazole—Pruritus—Valsartan—type 2 diabetes mellitus	3.71e-05	0.000215	CcSEcCtD
Pantoprazole—Dry mouth—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000215	CcSEcCtD
Pantoprazole—Decreased appetite—Losartan—type 2 diabetes mellitus	3.69e-05	0.000214	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.69e-05	0.000213	CcSEcCtD
Pantoprazole—Confusional state—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000212	CcSEcCtD
Pantoprazole—Pruritus—Orlistat—type 2 diabetes mellitus	3.67e-05	0.000212	CcSEcCtD
Pantoprazole—Fatigue—Losartan—type 2 diabetes mellitus	3.66e-05	0.000212	CcSEcCtD
Pantoprazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000211	CcSEcCtD
Pantoprazole—Oedema—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000211	CcSEcCtD
Pantoprazole—Vomiting—Gliclazide—type 2 diabetes mellitus	3.63e-05	0.00021	CcSEcCtD
Pantoprazole—Pain—Losartan—type 2 diabetes mellitus	3.63e-05	0.00021	CcSEcCtD
Pantoprazole—Constipation—Losartan—type 2 diabetes mellitus	3.63e-05	0.00021	CcSEcCtD
Pantoprazole—Rash—Gliclazide—type 2 diabetes mellitus	3.6e-05	0.000208	CcSEcCtD
Pantoprazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.6e-05	0.000208	CcSEcCtD
Pantoprazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.59e-05	0.000208	CcSEcCtD
Pantoprazole—Urticaria—Irbesartan—type 2 diabetes mellitus	3.58e-05	0.000207	CcSEcCtD
Pantoprazole—Shock—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000207	CcSEcCtD
Pantoprazole—Headache—Gliclazide—type 2 diabetes mellitus	3.58e-05	0.000207	CcSEcCtD
Pantoprazole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000207	CcSEcCtD
Pantoprazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000206	CcSEcCtD
Pantoprazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.56e-05	0.000206	CcSEcCtD
Pantoprazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.56e-05	0.000206	CcSEcCtD
Pantoprazole—Tachycardia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000206	CcSEcCtD
Pantoprazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.55e-05	0.000205	CcSEcCtD
Pantoprazole—Skin disorder—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000205	CcSEcCtD
Pantoprazole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000204	CcSEcCtD
Pantoprazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.5e-05	0.000202	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Pantoprazole—Dizziness—Valsartan—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Pantoprazole—Anorexia—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000201	CcSEcCtD
Pantoprazole—Dizziness—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000198	CcSEcCtD
Pantoprazole—Asthenia—Metformin—type 2 diabetes mellitus	3.43e-05	0.000198	CcSEcCtD
Pantoprazole—Hypotension—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000197	CcSEcCtD
Pantoprazole—Nausea—Gliclazide—type 2 diabetes mellitus	3.39e-05	0.000196	CcSEcCtD
Pantoprazole—Pruritus—Metformin—type 2 diabetes mellitus	3.38e-05	0.000196	CcSEcCtD
Pantoprazole—Urticaria—Losartan—type 2 diabetes mellitus	3.37e-05	0.000195	CcSEcCtD
Pantoprazole—Abdominal pain—Losartan—type 2 diabetes mellitus	3.35e-05	0.000194	CcSEcCtD
Pantoprazole—Body temperature increased—Losartan—type 2 diabetes mellitus	3.35e-05	0.000194	CcSEcCtD
Pantoprazole—Vomiting—Valsartan—type 2 diabetes mellitus	3.34e-05	0.000193	CcSEcCtD
Pantoprazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.32e-05	0.000192	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000192	CcSEcCtD
Pantoprazole—Rash—Valsartan—type 2 diabetes mellitus	3.31e-05	0.000191	CcSEcCtD
Pantoprazole—Dermatitis—Valsartan—type 2 diabetes mellitus	3.3e-05	0.000191	CcSEcCtD
Pantoprazole—Vomiting—Orlistat—type 2 diabetes mellitus	3.3e-05	0.000191	CcSEcCtD
Pantoprazole—Insomnia—Ramipril—type 2 diabetes mellitus	3.29e-05	0.00019	CcSEcCtD
Pantoprazole—Headache—Valsartan—type 2 diabetes mellitus	3.29e-05	0.00019	CcSEcCtD
Pantoprazole—Diarrhoea—Metformin—type 2 diabetes mellitus	3.27e-05	0.000189	CcSEcCtD
Pantoprazole—Rash—Orlistat—type 2 diabetes mellitus	3.27e-05	0.000189	CcSEcCtD
Pantoprazole—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000189	CcSEcCtD
Pantoprazole—Dermatitis—Orlistat—type 2 diabetes mellitus	3.26e-05	0.000189	CcSEcCtD
Pantoprazole—Headache—Orlistat—type 2 diabetes mellitus	3.25e-05	0.000188	CcSEcCtD
Pantoprazole—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000188	CcSEcCtD
Pantoprazole—Asthenia—Irbesartan—type 2 diabetes mellitus	3.23e-05	0.000187	CcSEcCtD
Pantoprazole—Somnolence—Ramipril—type 2 diabetes mellitus	3.23e-05	0.000187	CcSEcCtD
Pantoprazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.2e-05	0.000185	CcSEcCtD
Pantoprazole—Pruritus—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000185	CcSEcCtD
Pantoprazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000183	CcSEcCtD
Pantoprazole—Dizziness—Metformin—type 2 diabetes mellitus	3.16e-05	0.000183	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000182	CcSEcCtD
Pantoprazole—Fatigue—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000182	CcSEcCtD
Pantoprazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.13e-05	0.000181	CcSEcCtD
Pantoprazole—Nausea—Valsartan—type 2 diabetes mellitus	3.12e-05	0.00018	CcSEcCtD
Pantoprazole—Constipation—Ramipril—type 2 diabetes mellitus	3.11e-05	0.00018	CcSEcCtD
Pantoprazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.08e-05	0.000179	CcSEcCtD
Pantoprazole—Nausea—Orlistat—type 2 diabetes mellitus	3.08e-05	0.000178	CcSEcCtD
Pantoprazole—Asthenia—Losartan—type 2 diabetes mellitus	3.04e-05	0.000176	CcSEcCtD
Pantoprazole—Vomiting—Metformin—type 2 diabetes mellitus	3.04e-05	0.000176	CcSEcCtD
Pantoprazole—Rash—Metformin—type 2 diabetes mellitus	3.01e-05	0.000174	CcSEcCtD
Pantoprazole—Dermatitis—Metformin—type 2 diabetes mellitus	3.01e-05	0.000174	CcSEcCtD
Pantoprazole—Pruritus—Losartan—type 2 diabetes mellitus	3e-05	0.000174	CcSEcCtD
Pantoprazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3e-05	0.000174	CcSEcCtD
Pantoprazole—Headache—Metformin—type 2 diabetes mellitus	2.99e-05	0.000173	CcSEcCtD
Pantoprazole—Dizziness—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000173	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.97e-05	0.000172	CcSEcCtD
Pantoprazole—Diarrhoea—Losartan—type 2 diabetes mellitus	2.9e-05	0.000168	CcSEcCtD
Pantoprazole—Urticaria—Ramipril—type 2 diabetes mellitus	2.89e-05	0.000167	CcSEcCtD
Pantoprazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000166	CcSEcCtD
Pantoprazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000166	CcSEcCtD
Pantoprazole—Vomiting—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.000166	CcSEcCtD
Pantoprazole—Rash—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000165	CcSEcCtD
Pantoprazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.84e-05	0.000164	CcSEcCtD
Pantoprazole—Nausea—Metformin—type 2 diabetes mellitus	2.84e-05	0.000164	CcSEcCtD
Pantoprazole—Headache—Irbesartan—type 2 diabetes mellitus	2.82e-05	0.000164	CcSEcCtD
Pantoprazole—Dizziness—Losartan—type 2 diabetes mellitus	2.81e-05	0.000162	CcSEcCtD
Pantoprazole—Vomiting—Losartan—type 2 diabetes mellitus	2.7e-05	0.000156	CcSEcCtD
Pantoprazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.68e-05	0.000155	CcSEcCtD
Pantoprazole—Nausea—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.000155	CcSEcCtD
Pantoprazole—Rash—Losartan—type 2 diabetes mellitus	2.67e-05	0.000155	CcSEcCtD
Pantoprazole—Dermatitis—Losartan—type 2 diabetes mellitus	2.67e-05	0.000155	CcSEcCtD
Pantoprazole—Headache—Losartan—type 2 diabetes mellitus	2.66e-05	0.000154	CcSEcCtD
Pantoprazole—Asthenia—Ramipril—type 2 diabetes mellitus	2.61e-05	0.000151	CcSEcCtD
Pantoprazole—Pruritus—Ramipril—type 2 diabetes mellitus	2.57e-05	0.000149	CcSEcCtD
Pantoprazole—Nausea—Losartan—type 2 diabetes mellitus	2.52e-05	0.000146	CcSEcCtD
Pantoprazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.49e-05	0.000144	CcSEcCtD
Pantoprazole—Dizziness—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000139	CcSEcCtD
Pantoprazole—Vomiting—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000134	CcSEcCtD
Pantoprazole—Rash—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000133	CcSEcCtD
Pantoprazole—Dermatitis—Ramipril—type 2 diabetes mellitus	2.29e-05	0.000133	CcSEcCtD
Pantoprazole—Headache—Ramipril—type 2 diabetes mellitus	2.28e-05	0.000132	CcSEcCtD
Pantoprazole—Nausea—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000125	CcSEcCtD
Pantoprazole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.19e-06	8.73e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.19e-06	8.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.17e-06	8.69e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.14e-06	8.65e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	5.14e-06	8.65e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.14e-06	8.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.13e-06	8.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.13e-06	8.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.13e-06	8.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.1e-06	8.59e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.1e-06	8.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.07e-06	8.52e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	5.05e-06	8.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	5.05e-06	8.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	5.05e-06	8.5e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.04e-06	8.48e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.01e-06	8.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.01e-06	8.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.01e-06	8.43e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.01e-06	8.43e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	4.98e-06	8.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.96e-06	8.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.95e-06	8.33e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.93e-06	8.29e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.93e-06	8.29e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.93e-06	8.29e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.92e-06	8.28e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.91e-06	8.27e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	4.89e-06	8.23e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.85e-06	8.15e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.84e-06	8.14e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.81e-06	8.09e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	4.8e-06	8.07e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.8e-06	8.07e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.71e-06	7.93e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.7e-06	7.91e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.69e-06	7.9e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.62e-06	7.77e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.62e-06	7.77e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.61e-06	7.75e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.61e-06	7.75e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.61e-06	7.75e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.6e-06	7.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.57e-06	7.69e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.57e-06	7.69e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	4.53e-06	7.62e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.52e-06	7.61e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.51e-06	7.59e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.5e-06	7.58e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.5e-06	7.58e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.48e-06	7.54e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.46e-06	7.5e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.46e-06	7.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.45e-06	7.49e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—INS—type 2 diabetes mellitus	4.44e-06	7.47e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.43e-06	7.46e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.42e-06	7.43e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.42e-06	7.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.41e-06	7.43e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	4.4e-06	7.4e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.39e-06	7.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.39e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.39e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.39e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.38e-06	7.38e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.38e-06	7.37e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.38e-06	7.37e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.36e-06	7.34e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.35e-06	7.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.28e-06	7.21e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.27e-06	7.19e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.27e-06	7.19e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.26e-06	7.17e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.26e-06	7.17e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.26e-06	7.17e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.26e-06	7.17e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.23e-06	7.12e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.21e-06	7.09e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	4.21e-06	7.08e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.21e-06	7.08e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.17e-06	7.01e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.17e-06	7.01e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.09e-06	6.88e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	4.07e-06	6.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.06e-06	6.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.04e-06	6.8e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.99e-06	6.72e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.99e-06	6.72e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.95e-06	6.64e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.94e-06	6.62e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.94e-06	6.62e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.94e-06	6.62e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.9e-06	6.55e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	3.9e-06	6.55e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.86e-06	6.5e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	3.85e-06	6.47e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.83e-06	6.44e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.8e-06	6.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.78e-06	6.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.77e-06	6.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.77e-06	6.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.76e-06	6.32e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.75e-06	6.3e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.71e-06	6.24e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.68e-06	6.2e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.68e-06	6.2e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.67e-06	6.17e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.62e-06	6.09e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.6e-06	6.06e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.6e-06	6.06e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	3.56e-06	5.99e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.56e-06	5.99e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.55e-06	5.97e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.51e-06	5.91e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.5e-06	5.89e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.48e-06	5.85e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.48e-06	5.85e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.47e-06	5.84e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.45e-06	5.81e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.44e-06	5.79e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.44e-06	5.79e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.44e-06	5.78e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.43e-06	5.76e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.42e-06	5.75e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.41e-06	5.74e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.41e-06	5.74e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.41e-06	5.73e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.39e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.39e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.39e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.38e-06	5.69e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.37e-06	5.66e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.36e-06	5.66e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.35e-06	5.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.35e-06	5.64e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.31e-06	5.56e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.28e-06	5.52e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.28e-06	5.52e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.27e-06	5.51e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.27e-06	5.5e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.27e-06	5.49e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.22e-06	5.42e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.19e-06	5.37e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.19e-06	5.36e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.15e-06	5.29e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.13e-06	5.27e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	3.09e-06	5.21e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.07e-06	5.16e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.06e-06	5.14e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.04e-06	5.11e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.04e-06	5.11e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.04e-06	5.11e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	3.04e-06	5.11e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.02e-06	5.08e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.98e-06	5.02e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.98e-06	5.01e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.96e-06	4.98e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.95e-06	4.97e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.94e-06	4.95e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.94e-06	4.95e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.94e-06	4.95e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.94e-06	4.95e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.93e-06	4.93e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.89e-06	4.86e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.89e-06	4.86e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.89e-06	4.86e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.88e-06	4.85e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.87e-06	4.83e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.85e-06	4.79e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.82e-06	4.75e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.82e-06	4.75e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.81e-06	4.73e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.8e-06	4.72e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.78e-06	4.68e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.78e-06	4.67e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.77e-06	4.66e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.75e-06	4.62e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.75e-06	4.62e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.73e-06	4.59e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.68e-06	4.51e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.68e-06	4.51e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.64e-06	4.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.63e-06	4.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.63e-06	4.43e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.63e-06	4.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.62e-06	4.41e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.61e-06	4.4e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.6e-06	4.37e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.54e-06	4.28e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.51e-06	4.23e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.51e-06	4.22e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.46e-06	4.14e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.45e-06	4.12e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.41e-06	4.06e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.4e-06	4.04e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.37e-06	3.98e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.29e-06	3.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.29e-06	3.85e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.27e-06	3.82e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.27e-06	3.82e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.26e-06	3.8e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.26e-06	3.8e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.25e-06	3.79e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.24e-06	3.78e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.24e-06	3.78e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.23e-06	3.75e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.22e-06	3.73e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.2e-06	3.7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.16e-06	3.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.16e-06	3.63e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.16e-06	3.63e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.11e-06	3.54e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.11e-06	3.54e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.11e-06	3.54e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.07e-06	3.48e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.06e-06	3.46e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.02e-06	3.4e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.02e-06	3.39e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.97e-06	3.32e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.97e-06	3.31e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.97e-06	3.31e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.96e-06	3.3e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.96e-06	3.29e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.94e-06	3.26e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	1.93e-06	3.25e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.93e-06	3.24e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.92e-06	3.23e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-06	3.13e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.83e-06	3.07e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.8e-06	3.03e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.79e-06	3.01e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.77e-06	2.97e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.76e-06	2.96e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.74e-06	2.92e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.73e-06	2.91e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.71e-06	2.88e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.68e-06	2.83e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.68e-06	2.83e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.54e-06	2.59e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.51e-06	2.54e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.48e-06	2.49e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.36e-06	2.28e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-06	2.18e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-06	2.18e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-06	2e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.92e-07	1.67e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	9.68e-07	1.63e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	9.05e-07	1.52e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.73e-07	1.3e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.97e-07	1e-05	CbGpPWpGaD
